Sterile Fecal Microbiota Transplantation Boosts Anti-Inflammatory T-Cell Response in Ulcerative Colitis Patients.
Anton ChechushkovPavel DesyukevichTimir YakovlevLina Al AllafEvgenia V ShrainerVitalyi MorozovNina TikunovaPublished in: International journal of molecular sciences (2024)
Ulcerative colitis is a chronic immune-mediated disease of unclear etiology, affecting people of different ages and significantly reducing the quality of life. Modern methods of therapy are mainly represented by anti-inflammatory drugs and are not aimed at a specific pathogenetic factor. In this study, we investigated the effect of transplantation of sterile stool filtrate from healthy donors on the induction of anti-inflammatory immune mechanisms. It was shown that performing such a procedure in patients with ulcerative colitis caused the appearance of T helper cells in the blood, which reacted to the content of sterile stool filtrates in an antigen-specific manner and produced IL-10. At the same time, cells of the same patients before therapy in response to the addition of sterile stool filtrates were less reactive and predominantly produced IL-4, indicating its pro-inflammatory skewing. The obtained data demonstrated the effect of an anti-inflammatory shift in the T-helper response after transplantation of sterile stool filtrate, which increased and persisted for at least three months after the procedure.
Keyphrases
- ulcerative colitis
- anti inflammatory
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- cell cycle arrest
- peritoneal dialysis
- prognostic factors
- immune response
- stem cells
- signaling pathway
- cell proliferation
- patient reported outcomes
- cell death
- electronic health record
- mass spectrometry
- deep learning
- oxidative stress
- drug induced